1698-301-007 Ph3b Study (M21-488)
ClinicalTrials.gov NCT03850782
Research payments
$326,896
Through program year 2024, $326,896 in research payments was reported against 1698-301-007 Ph3b Study (M21-488), across 30 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03850782
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $326,896 | 30 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Eran Duzman Irvine, CA Named on 1 payment
- Abraham Park Kansas City, MO Named on 1 payment
- David Wirta Newport Beach, CA Named on 1 payment
- Husamuddin Ansari Boston, MA Named on 1 payment
- Ze Zhang New Orleans, LA Named on 1 payment
- Mark Slabaugh Columbus, OH Named on 1 payment
- Daniel Nolan San Antonio, TX Named on 1 payment
- Jeffrey Kammer Nashville, TN Named on 1 payment
- Shailesh Gupta Deerfield Beach, FL Named on 1 payment
- Tina Xia Bala Cynwyd, PA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.